Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MEDICLIN AG Earnings Release 2007

Nov 9, 2007

280_rns_2007-11-09_4bae860a-30ea-4837-9cf2-fc262285b75c.html

Earnings Release

Open in viewer

Opens in your device viewer

News Details

Corporate | 9 November 2007 10:29

MediClin AG:Business development in the first 9 months 2007 improved against previous year despite increased costs – strong third quarter

MediClin AG / Quarter Results

Release of a Corporate News, transmitted by DGAP - a company of EquityStory
AG.
The issuer / publisher is solely responsible for the content of this announcement.


Frankfurt, November 9, 2007 – The Board of Management of MEDICLIN
Aktiengesellschaft (MediClin) is satisfied with the past course of business
in the 2007 financial year. Consolidated sales for the first nine months of
the 2007 financial year were EUR 292.4 mill., an increase of EUR 11.2 mill.
or 4.0% over the comparable figure of last year’s period. Despite rising
costs especially for materials and staff, the consolidated operating result
rose by 12.6 % or EUR 1.5 mill. to EUR 13.4 mill. (9M 2006: EUR 11.9 mill.)
during the reporting period. At a financial result improved by EUR 0.5
mill. to EUR -3.5 mill., the result before tax was EUR 9.9 mill., an about
25 % or EUR 2.0 mill. increase above previous year’s figure. However, the
result attributable to the shareholders of MediClin was affected by outlay
resulting from the revaluation of deferred taxes totalling EUR 4.1 mill.,
thus amounting to EUR 2.6 mill. (9M 2006: EUR 6.7 mill.).

Sales increase in all three segments
Sales gains were generated in all three segments as compared to the
nine-month period of 2006. Sales in the post-acute segment amounted to EUR
167.9 mill., 4.7% up against previous year’s figure. The segment result was
EUR 1.4 Mio. mill. Despite budget cuts due to the introduction of the
restructuring contribution to be made by hospitals, the acute segment
achieved a sales increase of 2.1% reaching EUR 116.9 mill. The segment
result was EUR 12.2 mill. The nursing care segment shows sales of EUR 7.6
mill., thus up EUR 1.3 mill against previous year. The segment result of
EUR -0.2 mill. meets previous year’s result.

Nursing days, number of cases and occupancy rates increased
The number of nursing days provided in the Group rose by 4.3 % or 69,651
days during the first nine months of 2007 and reached 1,696,538 days (9 M
2006: 1,626,887). The case numbers increased in the Group by 3.5 % up
81,715 cases (9 M 2006: 78,932 cases). The occupancy rates of the Group
improved from 78.2% auf 84.2%.

Ausblick
For 2007, the Management Board expects further on moderate sales growth and
an operating result on a par with that of the 2006 financial year, despite
budget cutbacks resulting from contributions to restructuring in the acute
segment, as well as expected cost increases in all areas.
The 2008 corporate tax reform has caused a strain on results after tax in
the third quarter of 2007, namely in a one-off and non-cash item of EUR 4.1
mill., and will thereby impact the entire 2007 financial year accordingly.
The effect has been the result of the necessary revaluation due to the
reduction of the corporate tax rate of 25 % to 15% commencing 1 January
2008.

The interim report as of September 30, 2007 will be available on
www.mediclin.de.

About MediClin AG (Ticker: MED; WKN: 659 510)
MediClin AG is a nation-wide clinic operator and large provider of services
in the area of Psycho- and Neurosciences as well as Orthopaedic. With 30
clinics and 8 nursing care facilities and 3 Medizinische Versorgungszentren
(medical care units) in 11 federal states MediClin has a total capacity of
approximately 7,400 beds. MediClin’s facilities include acute care clinics,
i.e., general hospitals, special treatment facilities, specialised
hospitals and clinics for post-acute treatment and medical rehabilitation.
MediClin has approximately 6,900 employees.

Important notice:
This press release includes future-oriented statements which are based on
assumptions and estimates. While MediClin AG is of the opinion that these
assumptions and estimates are correct, the actual future developments and
actual future results may deviate from these assumptions and estimates due
to the impact of various factors such as changes in the economic conditions
in Germany, legal changes concerning the health system, changes relating to
cost providers’ expense behaviour. MediClin does not assume liability and
gives no warranty that future developments and the income actually achieved
in the future will comply with the assumptions and estimates stated in this
press release.
09.11.2007 Financial News transmitted by DGAP


Language: English
Issuer: MediClin AG
c/o MediClin Geschäftsführungs-GmbH Okenstraße 27
77652 Offenburg
Deutschland
Phone: +49 (0)69 25 60 02-0
Fax: +49 (0)69 25 60 02-69
E-mail: [email protected]
Internet: www.mediclin.de
ISIN: DE0006595101
WKN: 659510
Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
in Berlin, Düsseldorf, Hamburg, Stuttgart

End of News DGAP News-Service